TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
584,432
|
638,549
|
680,580 |
| Financial expenses |
25
|
81
|
426 |
| Earnings before taxes |
23,210
|
24,477
|
23,996 |
| EBITDA |
21,743
|
22,731
|
24,699 |
| Total assets |
259,951
|
252,777
|
250,512 |
| Current assets |
259,529
|
252,588
|
250,149 |
| Current liabilities |
49,808
|
60,165
|
76,523 |
| Equity capital |
197,659
|
179,884
|
161,098 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
23
|
28
|
31 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
71.2%
|
64.3% |
| Turnover per employee |
25,410
|
22,805
|
21,954 |
| Profit as a percentage of turnover |
4.0%
|
3.8%
|
3.5% |
| Return on assets (ROA) |
8.9%
|
9.7%
|
9.7% |
| Current ratio |
521.1%
|
419.8%
|
326.9% |
| Return on equity (ROE) |
11.7%
|
13.6%
|
14.9% |
| Change turnover |
-54,117
|
-42,031
|
-83,600 |
| Change turnover % |
-8%
|
-6%
|
-11% |
| Chg. No. of employees |
-5
|
-3
|
0 |
| Chg. No. of employees % |
-18%
|
-10%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.